{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T12:58:27Z","timestamp":1770987507600,"version":"3.50.1"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,9]]},"abstract":"<jats:sec>\n            <jats:title>OBJECTIVE:<\/jats:title>\n            <jats:p>To estimate the frequency and reasons for inadequate group B streptococci (GBS) prophylaxis at our institution and to estimate what proportion of cases can be avoided with perfect protocol adherence.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS:<\/jats:title>\n            <jats:p>This was a retrospective cohort study of neonates born to GBS-colonized women who received inadequate prophylaxis between April 30, 2013, and May 1, 2014. The maternal chart was analyzed to categorize each case as avoidable (adequate time on labor and delivery to receive antibiotics 4 hours before birth and \u03b2-lactam antibiotic-eligible) or unavoidable and to determine whether a violation of the 2010 Centers for Disease Control and Prevention (CDC) protocol (delayed or incorrect antibiotics) occurred.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS:<\/jats:title>\n            <jats:p>A total of 197 of 488 (40.4%, 95% confidence interval 36.1\u201344.8%) newborns of group B-colonized women received inadequate prophylaxis. Of these, 157 cases (79.7%, 73.4\u201384.8%) were unavoidable and would have occurred even with perfect protocol adherence. The 40 (20.3%, 15.3\u201326.5%) avoidable cases due to protocol violations resulted from delayed antibiotic administration (first dose of antibiotics more than 1 hour after admission [median 9.33 hours, range 3.83\u201325 hours] in 25 patients; no antibiotics in four patients; total 29 patients, 72.5%) or incorrect antibiotic selection (11 patients, 27.5%).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS:<\/jats:title>\n            <jats:p>Forty percent of patients received inadequate prophylaxis, and four of five cases are unavoidable with our current labor management and the 2010 CDC guidelines. Timeliness and selection of antibiotics remain areas for improvement, but the overall effects on sepsis prevention will be modest.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/aog.0000000000001564","type":"journal-article","created":{"date-parts":[[2016,8,19]],"date-time":"2016-08-19T20:35:50Z","timestamp":1471638950000},"page":"598-603","source":"Crossref","is-referenced-by-count":8,"title":["Avoiding Inadequate Intrapartum Antibiotic Prophylaxis for Group B Streptococci"],"prefix":"10.1097","volume":"128","author":[{"given":"Sarah","family":"Bienenfeld","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura G.","family":"Rodriguez-Riesco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kent D.","family":"Heyborne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230711","article-title":"Prevention of early-onset group B streptococcal disease in newborns"},{"key":"R2-20230711","first-page":"1","article-title":"Prevention of perinatal group B streptococcal disease: a public health perspective","volume":"45","year":"1996","journal-title":"MMWR Recomm Rep"},{"key":"R3-20230711","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1097\/INF.0b013e318180b3b9","article-title":"Revisiting the need for vaccine prevention of late-onset neonatal group B streptococcal disease: a multistate, population-based analysis","volume":"27","author":"Jordan","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"R4-20230711","first-page":"109","article-title":"Trends in perinatal group B streptococcal disease\u2014United States, 2000\u20132006","volume":"58","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R5-20230711","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1001\/jama.299.17.2056","article-title":"Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005","volume":"299","author":"Phares","year":"2008","journal-title":"JAMA"},{"key":"R6-20230711","first-page":"1","article-title":"Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC","volume":"51","author":"Schrag","year":"2002","journal-title":"MMWR Recomm Rep"},{"key":"R7-20230711","first-page":"1","article-title":"Prevention of perinatal group B streptococcal disease revised guidelines from CDC","volume":"59","author":"Verani","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"R8-20230711","first-page":"1","article-title":"Prevention of perinatal group B streptococcal disease: revised guidelines from CDC, 2010","volume":"59","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"R9-20230711","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1097\/AOG.0b013e318219229b","article-title":"Prevention of early-onset group B streptococcal disease in newborns. Committee Opinion No. 485. American College of Obstetricians and Gynecologists","volume":"117","year":"2011","journal-title":"Obstet Gynecol"},{"key":"R10-20230711","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1067\/mob.2001.113875","article-title":"The effectiveness of risk-based intrapartum chemoprophylaxis for the prevention of early-onset neonatal group B streptococcal disease","volume":"184","author":"Lin","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"R11-20230711","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa020205","article-title":"A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates","volume":"347","author":"Schrag","year":"2002","journal-title":"N Engl J Med"},{"key":"R12-20230711","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/jp.2008.115","article-title":"Continued early onset group B streptococcal infections in the era of intrapartum prophylaxis","volume":"29","author":"Pulver","year":"2009","journal-title":"J Perinatol"},{"key":"R13-20230711","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1542\/peds.2004-2275","article-title":"Early-onset group B streptococcal disease in the era of maternal screening","volume":"115","author":"Puopolo","year":"2005","journal-title":"Pediatrics"},{"key":"R14-20230711","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1056\/NEJMoa0806820","article-title":"Evaluation of universal antenatal screening for group B streptococcus","volume":"360","author":"Van Dyke","year":"2009","journal-title":"N Engl J Med"},{"key":"R16-20230711","first-page":"162","article-title":"Announcements: smartphone application available for preventing group B streptococcus infections","volume":"63","year":"2014","journal-title":"MMWR Recomm Rep"},{"key":"R17-20230711","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1097\/AOG.0b013e3181dd916f","article-title":"Adherence to perinatal group B streptococcal prevention guidelines","volume":"115","author":"Goins","year":"2010","journal-title":"Obstet Gynecol"},{"key":"R18-20230711","doi-asserted-by":"crossref","first-page":"917304","DOI":"10.1155\/2013\/917304","article-title":"Guideline adherence for intrapartum group B streptococci prophylaxis in penicillin-allergic patients","volume":"2013","author":"Paccione","year":"2013","journal-title":"Infect Dis Obstet Gynecol"},{"key":"R19-20230711","doi-asserted-by":"crossref","first-page":"150.e1","DOI":"10.1016\/j.ajog.2010.08.063","article-title":"Group B streptococcus prophylaxis in patients who report a penicillin allergy: a follow-up study","volume":"204","author":"Critchfield","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"R20-20230711","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/AOG.0000000000001297","article-title":"Use of Cefazolin for Group B Streptococci Prophylaxis in Women Reporting a Penicillin Allergy Without Anaphylaxis","volume":"127","author":"Briody","year":"2016","journal-title":"Obstet Gynecol"},{"key":"R21-20230711","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1056\/NEJMra993637","article-title":"Cephalosporin allergy","volume":"345","author":"Kelkar","year":"2001","journal-title":"N Engl J Med"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006250-201609000-00024","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T19:02:54Z","timestamp":1689102174000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006250-201609000-00024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000001564","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]}}}